Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Pharmaceutical Flow Cytometry & Imaging Show

10 Oct 2012 - 11 Oct 2012 - AstraZeneca Conference Centre, AstraZeneca R&D Alderley Park, UK



Bookmark and Share


Following on from the great success and positive feedback from our previous meetings, we are continuing to include topics of current interest by adding Phenotypic Screening and Personalised Health Care to the areas that will be addressed.  Typical attendees will be colleagues from small-to mid-sized biotech companies, contract research organisations and global pharmaceutical companies. The content of this free two day meeting will also include other industrial-based themes covering the drug development journey from discovery to clinical evaluation.

Topics over two days will include:

Lead Generation - high throughput / high content screening
Pharmaceuticals - monoclonal antibodies and fragments 
Drug attrition - safety and secondary pharmacology
Stem cells - range of application in discovery research and therapy
Biomarkers - method validation, clinical study support & outsourcing of cell-based assays
New techniques and applications - novel agents, instruments and analysis
Phenotypic Screening - complex and cell based assays
Personalised Health Care - decision making biomarkers, companion diagnostics & life-cycle management

Posters - Submit an Abstract to:  posters@elrig.org
Exhibition Trade Show - Book your stand at www.elrig.org
2 Days Scientific Sessions - Leaders in Flow and Imaging will be presenting

Register and Attend FREE OF CHARGE go to: www.elrig.org


Further information
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Molecule May Affect Gaucher, Parkinson's Disease
Research has identified a molecule that restores activity of a dysfunctional enzyme linked to Gaucher and Parkinson's disease.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!